FDA approved Alhemo® injection as once-daily prophylactic treatment to reduce frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B
| | | |

FDA approved Alhemo® injection as once-daily prophylactic treatment to reduce frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B

On Dec. 20, 2024, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Alhemo®…

Massachusetts General Hospital Received Transformational Gift of $100 Million from Herb Chambers to Revolutionize Cancer Care for Patients and Families
| | | | |

Massachusetts General Hospital Received Transformational Gift of $100 Million from Herb Chambers to Revolutionize Cancer Care for Patients and Families

On Dec. 11, 2024, Massachusetts General Hospital (MGH), founding member of the Mass General Brigham healthcare system, announced…